Bioorganic & Medicinal Chemistry Letters 2006-05-15

Tetrazole thioacetanilides: potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant.

Ester Muraglia, Olaf D Kinzel, Ralph Laufer, Michael D Miller, Gregory Moyer, Vandna Munshi, Federica Orvieto, Maria Cecilia Palumbi, Giovanna Pescatore, Michael Rowley, Peter D Williams, Vincenzo Summa

Index: Bioorg. Med. Chem. Lett. 16(10) , 2748-52, (2006)

Full Text: HTML

Abstract

A series of aryltetrazolylacetanilides was synthesized and evaluated as HIV-1 non-nucleoside reverse transcriptase inhibitors on wild-type virus and on the clinically relevant K103N mutant strain. Extensive SAR investigation led to potent compounds, with nanomolar activity on K103N, and orally bioavailable in rats.

Related Compounds

  • Thioacetanilide

Related Articles:

The metabolism of thioacetanilide in the rat.

1983-08-01

[Xenobiotica 13(8) , 475-82, (1983)]

1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation.

2009-09-01

[Bioorg. Med. Chem. 17(17) , 6374-9, (2009)]

Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

2009-08-15

[Bioorg. Med. Chem. 17(16) , 5775-81, (2009)]

Effects from filtration, capping agents, and presence/absence of food on the toxicity of silver nanoparticles to Daphnia magna.

2010-12-01

[Bioorg. Med. Chem. 20(18) , 5527-36, (2012)]

[Substantiation of maximum permissible levels of thioacylanilide in the air of work areas].

1986-07-01

[Gig. Tr. Prof. Zabol. (7) , 51-2, (1986)]

More Articles...